Second Trimester Medical Abortion with Mifepristone-Misoprostol and Misoprostol Alone: A Review of Methods and Management

Reproductive Health Matters

Volumn 16, Issue 31 SUPPL., 2008, Pages 162-172

  Gemzell Danielsson, Kristina ^a   Lalitkumar, Sujata ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

medical abortion; mid level providers; mifepristone; misoprostol; second trimester abortion

Indexed keywords

ANALGESIC AGENT; ETHACRIDINE LACTATE; GEMEPROST; MIFEPRISTONE; MISOPROSTOL; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN DERIVATIVE;

ABDOMINAL CRAMP; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CERVICAL SPINE INJURY; CESAREAN SECTION; CHILL; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUNSELING; DIARRHEA; DILATION AND EVACUATION; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INHIBITION; DRUG SAFETY; EMERGENCY CARE; FEVER; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; INFECTION; LABORATORY TEST; MEDICAL ABORTION; META ANALYSIS; MORBIDITY; NAUSEA AND VOMITING; PAIN; PATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER ABORTION; SYSTEMATIC REVIEW; TRANSVAGINAL ECHOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; UTERUS RUPTURE; VAGINA BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 50649097206     PISSN: 09688080     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-8080(08)31371-8     Document Type: Article

References (73)

1. Drey E.A., Foster D.G., Jackson R.A., et al. Risk factors associated with presenting for abortion in the second trimester. Obstetrics & Gynecology 107 1 (2006) 128-135
2. Grimes D.A. The continuing need for late abortions. JAMA 280 8 (1998) 747-750
3. Bujalkova M. Birth control in antiquity. Bratisl Lek Listy 108 3 (2007) 163-166
4. Medical Methods for Termination of Pregnancy. WHO Technical Report Series 871. World Health Organization, Geneva, 1997.
5. Urquhart D.R., and Templeton A.A. Mifepristone (RU 486) and second-trimester termination. Lancet 2 8572 (1987) 1405
6. Silvestre L., Dubois C., Renault M., et al. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience. New England Journal of Medicine 322 10 (1990) 645-648
7. Gottlieb C., and Bygdeman M. The use of antiprogestin (RU 486) for termination of second trimester pregnancy. Acta Obstetrica et Gynecologica Scandinavica 70 3 (1991) 199-203
8. Bygdeman M., and Swahn M.L. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception 32 1 (1985 Jul) 45-51
9. Swahn M.L., and Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. British Journal of Obstetrics & Gynecology 95 2 (1988) 126-134
10. Royal College of Obstetricians and Gynaecologists. Induced Abortion Guidelines No.11 (1997), RCOG, London
11. Bartlett L.A., Berg C.J., Shulman H.B., et al. Risk factors for legal induced abortion-related mortality in the United States. Obstetrics & Gynecology 103 4 (2004) 729-737
12. Elam-Evans L.D., Strauss L.T., Herndon J., et al. Abortion surveillance - United States, 2000. Morbidity and Mortality Weekly Report Surveillance Summaries 52 12 (2003) 1-32
13. Boyd P.A., Tondi F., Hicks N.R., et al. Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study. BMJ 328 7432 (2004) 137
14. Safe Abortion: Technical and Policy Guidelines for Health Systems (2003), World Health Organization, Geneva
15. Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. Guidelines No.7. London, 2004.
16. Grimes D.A., Schulz K.F., Cates Jr. W., et al. Mid-trimester abortion by dilatation and evacuation: a safe and practical alternative. New England Journal of Medicine 296 20 (1977) 1141-1145
17. Autry A.M., Hayes E.C., Jacobson G.F., et al. A comparison of medical induction and dilation and evacuation for second-trimester abortion. American Journal of Obstetrics & Gynecology 187 2 (2002) 393-397
18. Report of Confidential Enquires into Maternal Deaths in the United Kingdom (1994-1996) Why Mothers Die. Department of Health. London: Her Majesty's Stationary Office. 1997.
19. Lalitkumar S., Bygdeman M., and Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Human Reproduction Update 13 1 (2007) 37-52
20. World Health Organization. Unsafe Abortion: Global Estimates of the Incidence of Unsafe Abortion and Associated Mortality in 2000. 4th ed. (2004), WHO, Geneva
21. Johannisson E., Oberholzer M., Swahn M.L., et al. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception 39 1 (1989) 103-117
22. Norman J.E., Thong K.J., and Baird D.T. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 338 8777 (1991) 1233-1236
23. Radestad A., Christensen N.J., and Stromberg L. Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study. Contraception 38 3 (1988) 301-312
24. Mitchell M.D. Regulation of eicasanoid biosynthesis during pregnancy and parturition. In: Hiller K. (Ed). Eicsanoids and Reproduction (1987), MTP Press, Lancaster 108-127
25. Ho P.C., Chan Y.F., and Lau W. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial. Contraception 53 5 (1996) 281-283
26. Bartley J., and Baird D.T. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. BJOG 109 11 (2002) 1290-1294
27. Tang O.S., Gemzell-Danielsson K., and Ho P.C. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects. International Journal of Gynecology & Obstetrics 99 Suppl 2 (2007) S160-S167
28. Thong K.J., and Baird D.T. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy. Contraception 46 1 (1992) 11-17
29. Ho P.C., Tsang S.S., and Ma H.K. Reducing the induction to abortion interval in termination of second trimester pregnancies: a comparison of mifepristone with laminaria tent. British Journal of Obstetrics & Gynaecology 102 8 (1995) 648-651
30. Ho P.C., Ngai S.W., Liu K.L., et al. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstetrics and Gynecology 102 8 (1995) 648-651
31. el-Refaey H., and Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Human Reproduction 10 2 (1995) 475-478
32. Ngai S.W., Tang O.S., and Ho P.C. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Human Reproduction 15 10 (2000) 2205-2208
33. Hamoda H., Ashok P.W., Flett G.M., et al. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation. Human Reproduction 20 8 (2005) 2348-2354
34. Tang O.S., Lau W.N., Chan C.C., et al. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG 111 9 (2004) 1001-1005
35. Heikinheimo O., Suhonen S., and Haukkamaa M. One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy. Reproductive BioMedicine Online 8 2 (2004) 236-239
36. Nilas L., Glavind-Kristensen M., Vejborg T., et al. One or two day mifepristone-misoprostol interval for second trimester abortion. Acta Obstetricia et Gynecologica Scandinavica 86 9 (2007) 1117-1121
37. UK Multicentre Study Group. Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. Contraception 56 6 (1997) 361-366
38. Tang O.S., Thong K.J., and Baird D.T. Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases. Contraception 64 1 (2001) 29-32
39. Cameron I.T., Michie A.F., and Baird D.T. Prostaglandin-induced pregnancy termination: further studies using gemeprost (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) vaginal pessaries in the early second trimester. Prostaglandins 34 1 (1987) 111-117
40. Thong K.J., and Baird D.T. An open study comparing two regimens of gemeprost for the termination of pregnancy in the second trimester. Acta Obstetricia et Gynecologica Scandinavica 71 3 (1992) 191-196
41. Armatage R.J., and Luckas M.J. A randomized trial of 2 regimens for the administration of vaginal prostaglandins (gemeprost) for the induction of midtrimester abortion. The Australian and New Zealand Journal of Obstetrics and Gynaecology 36 3 (1996) 296-299
42. Wong K.S., Ngai C.S., Wong A.Y., et al. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial. Contraception 58 4 (1998) 207-210
43. Bebbington M.W., Kent N., Lim K., et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. American Journal of Obstetrics & Gynecology 187 4 (2002) 853-857
44. Jain J.K., Meckstroth K.R., and Mishell Jr. D.R. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. American Journal of Obstetrics & Gynecology 181 6 (1999) 1386-1391
45. Wong K.S., Ngai C.S., Yeo E.L., et al. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Human Reproduction 15 3 (2000) 709-712
46. Herabutya Y., Chanrachakul B., and Punyavachira P. Vaginal misoprostol in termination of second trimester pregnancy. Journal of Obstetrics and Gynaecology Research 26 2 (2000) 121-125
47. Herabutya Y., Chanrachakul B., and Punyavachira P. Second trimester pregnancy termination: a comparison of 600 and 800 micrograms of intravaginal misoprostol. Journal of Obstetrics and Gynaecology Research 27 3 (2001) 125-128
48. Pongsatha S., and Tongsong T. Second trimester pregnancy termination with 800 mcg vaginal misoprostol. Journal of Medical Association of Thailand 84 6 (2001) 859-863
49. Dodd J.M., and Crowther C.A. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 125 1 (2006 Mar 1) 3-8
50. Ho P.C., Blumenthal P.D., Gemzell-Danielsson K., et al. Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. International Journal of Gynaecology & Obstetrics 99 Suppl 2 (2007) S178-S181
51. Bartley J., Brown A., Elton R., et al. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Human Reproduction 16 10 (2001) 2098-2102
52. Van Look P.F., and Bygdeman M. Antiprogestational steroids: a new dimension in human fertility regulation. Oxford Reviews of Reproductive Biology 11 (1989) 2-60
53. Thong K.J., and Baird D.T. Induction of second trimester abortion with mifepristone and gemeprost. British Journal of Obstetrics & Gynaecology 100 8 (1993) 758-761
54. Gemzell-Danielsson K., and Ostlund E. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases. Acta Obstetricia et Gynecologica Scandinavica 79 8 (2000) 702-706
55. Hamoda H., Ashok P.W., Flett G.M., et al. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. BJOG 111 9 (2004) 996-1000
56. Li C.F., Wong C.Y., Chan C.P., et al. A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy. Contraception 67 2 (2003) 101-105
57. Creinin M.D., and Shulman T. Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion. Contraception 56 3 (1997) 165-168
58. Fiala C., Swahn M.L., Stephansson O., et al. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation. Human Reproduction 20 11 (2005) 3072-3077
59. Ashok P.W., Templeton A., Wagaarachchi P.T., et al. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 69 1 (2004) 51-58
60. Norman J.E. Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin. British Journal of Obstetrics and Gynaecology 102 4 (1995) 332-333
61. Chen M., Shih J.C., Chiu W.T., et al. Separation of cesarean scar during second-trimester intravaginal misoprostol abortion. Obstetrics & Gynecology 94 5 Pt 2 (1999) 840
62. Wiener J.J., and Evans A.S. Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report. British Journal of Obstetrics and Gynaecology 97 11 (1990) 1061-1062
63. Atienza M.F., Burkman R.T., and King T.M. Midtrimester abortion induced by hyperosmolar urea and prostaglandin F2 alpha in patients with previous cesarean section: clinical course and potential for uterine rupture. American Journal of Obstetrics & Gynecology 138 1 (1980) 55-59
64. Royal College of Obstetricians and Gynaecologists. Termination of Pregnancy for Fetal Abnormality in England, Scotland and Wales (1996), RCOG, London
65. Drey E.A., Foster D.G., Jackson R.A., et al. Risk factors associated with presenting for abortion in the second trimester. Obstetrics & Gynecology 107 1 (2006 Jan) 128-135
66. Elimian A., Verma U., and Tejani N. Effect of causing fetal cardiac asystole on second-trimester abortion. Obstetrics & Gynecology 94 1 (1999) 139-141
67. Bhide A., Sairam S., Hollis B., et al. Comparison of feticide carried out by cordocentesis versus cardiac puncture. Ultrasound in Obstetrics and Gynecology 20 3 (2002) 230-232
68. Senat M.V., Fischer C., Bernard J.P., et al. The use of lidocaine for fetocide in late termination of pregnancy. BJOG 110 3 (2003) 296-300
69. Ashok P.W., and Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. British Journal of Obstetrics and Gynaecology 106 7 (1999) 706-710
70. Gautam R., and Agrawal V. Early medical termination pregnancy with methotrexate and misoprostol in lower segment cesarean section cases. Journal of Obstetrics and Gynaecology Research 29 4 (2003) 251-256
71. Miller D.A., Diaz F.G., and Paul R.H. Vaginal birth after cesarean: a 10-year experience. Obstetrics & Gynecology 84 2 (1994) 255-258
72. Boulot P., Hoffet M., Bachelard B., et al. Late vaginal induced abortion after a previous cesarean birth: potential for uterine rupture. Gynecologic and Obstetric Investigation 36 2 (1993) 87-90
73. Berghahn L., Christensen D., and Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstetrics & Gynecology 98 5 Pt. 2 (2001) 976-977